Agobrim 0,2 % Eye Drops
PDF Leaflet Revision Date: 30 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Lowering intraocular pressure in open angle glaucoma or ocular hypertension.
Dosage (summary)
One drop in affected eye(s) twice daily, 12 hours apart.
Onset of Action / Duration
Onset: 2 hours, Duration: Not specified.
Special Populations
- Paediatric patients under 2 years
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- MAO inhibitors
- CNS depressants
- Antihypertensives
- Cardiac glycosides
Contraindications
- Hypersensitivity to brimonidine or excipients
- MAO inhibitor therapy
Common side effects
- Oral dryness
- Ocular hyperaemia
- Burning/stinging
- Dizziness
- Headache
Counselling Points
- Wait 15 mins before reinserting contact lenses
- Monitor for drowsiness
- Avoid use in children under 2
Serious warnings
- Caution in severe cardiovascular disease
- Potential for allergic reactions
- May cause drowsiness
Important Disclaimer
The Agobrim 0,2 % Eye Drops professional information leaflet below is the property of Fdc Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
